Genome Engineering in Accelerating Discovery and Preclinical Applications

Speaker: Dan (Xiaodan) Wang, Ph.D. Associate Director of Gene Targeting

When CRISPR/Cas9 technology is applied to generate Genetically Modified Models, common challenges include transgene silencing, karyotype abnormalities, off-targeting risks, random integrations and mosaicism.
To minimize the off-targeting effect and enhance the specificity, we design sgRNAs by combining the results from CCTop, Sanger and CrispRGold; The sgRNA is chosen based on UCA assay and other factors.
Use of our CRISPR-based Extreme Genome Editing technology improves the efficiency of large fragment knock-in by up to 10-20 fold, meaning we can generate targeted cell lines, mouse and rat models in industry-leading timelines with a 98% success rate.

Please fill out the form below to request a download of this Webinar

First Name *

Last Name *

Work Email *

Company/ Institution*

Country *

State/ Province *

How did you hear about us? *